Vol. 36 No. 5 (2019): October
Documents

Consensus of infectious complications in patients treated with selected biological therapies. Second part: Chilean Guidelines for Prevention of Infections associated to use of Biological Therapies (PREVITEB)

PDF (Español (España))
  • Inés Cerón,
  • Cecilia Vizcaya,
  • Pilar Gambra,
  • Marcela Ferres,
  • Teresa Bidart,
  • Tania López,
  • María Paz Acuña,
  • Ana María Álvarez,
  • Marcela Zubieta,
  • Marcela Rabello,
  • Luisa Durán,
  • Ricardo Rabagliati

Published 2019-11-25

Keywords

How to Cite

1.
Cerón I, Vizcaya C, Gambra P, Ferres M, Bidart T, López T, Acuña MP, Álvarez AM, Zubieta M, Rabello M, Durán L, Rabagliati R. Consensus of infectious complications in patients treated with selected biological therapies. Second part: Chilean Guidelines for Prevention of Infections associated to use of Biological Therapies (PREVITEB). Rev. Chilena. Infectol. [Internet]. 2019 Nov. 25 [cited 2025 Nov. 19];36(5). Available from: https://revinf.cl/index.php/revinf/article/view/601

Copyright (c) 2019 Inés Cerón, Cecilia Vizcaya, Pilar Gambra, Marcela Ferres, Teresa Bidart, Tania López, María Paz Acuña, Ana María Álvarez, Marcela Zubieta, Marcela Rabello, Luisa Durán, Ricardo Rabagliati

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

The use of biological therapies has meant a great improvement in the management of several conditions like autoimmune, neoplastic or others diseases. Although its use has implied significant improvements in the prognosis of these diseases, it is not exempt from complications: infectious diseases as one of them. The objective of this consensus was to evaluate, from an infectious viewpoint, the safeness of the most frequently used biological therapies and give recommendations for the prevention of infections in patients treated with these drugs. These recommendations were based on the highest quality evidence available for the selected biologics. The consensus counts of 2 manuscripts. This second part is a guideline that details these recommendations through screening strategies, prophylactic therapies and vaccines indications for bacterial, mycobacterial, viral, fungal and parasitic infections, both for adults and children.
PDF (Español (España))